ICMR
Clinical studies
Our Research Focus
We conduct Phase I, II, III, and IV clinical trials involving pharmacological treatments and technological equipment in the field of dermatology and related specialties. Currently, our research focuses on new therapeutic options for conditions such as alopecia areata, moderate-to-severe psoriasis, notalgia paresthetica, vitiligo, atopic dermatitis, and hidradenitis suppurativa. All our studies are conducted in accordance with the highest scientific and ethical standards, with the aim of improving disease management and enhancing patients’ quality of life.
Ongoing studies
CONDITION
Moderate to severe psoriasis in adolescents
Clinical study to evaluate treatments for adolescents with moderate to severe psoriasis.
Patients aged 12 to 18 years
Psoriasis affecting 10% or more of body surface area
CONDITION
Moderate to severe atopic dermatitis
Clinical study aimed at evaluating new therapeutic options for atopic dermatitis in adults.
Patients aged 18 years or older
Atopic dermatitis affecting 10% or more of body surface area
CONDITION
Hidradenitis suppurativa
Study designed to assess the effectiveness of innovative treatments in people with active hidradenitis suppurativa.
Patients aged 18 years or older
Presence of five or more lesions in at least two different body areas
CONDITION
Palmoplantar pustulosis
Clinical study to assess the effectiveness of treatments for patients with palmoplantar pustulosis.
Patients aged 18 years or older with palmoplantar pustulosis
Presence of more than five pustules (collections of white-yellowish pus) on the palms of the hands and/or soles of the feet
CONDITION
Moderate to severe psoriasis in people over 40
Clinical study to evaluate treatments for moderate to severe psoriasis.
Patients aged over 40 years
Psoriasis affecting 10% or more of body surface area
Presence of one or more associated conditions, such as: type II diabetes mellitus, arterial hypertension, elevated cholesterol levels, overweight
CONDITION
Lichen planopilaris
Clinical study to assess the effectiveness of treatments for patients with lichen planopilaris.
Patients aged 18 years or older
Active lichen planopilaris, defined by the presence of inflammation, itching, pain or burning sensation of moderate to high intensity
CONDITION
Nummular eczema
Clinical study to evaluate the effectiveness of therapies for patients with nummular eczema.
Patients aged 18 years or older
Nummular eczema of at least one year’s duration, with poor response to topical treatments
Conditions
Research areas
At ICMR we are prepared to develop research in all dermatological indications, with special attention to:
Psoriasis
We analyze genetic and immune factors to improve the approach to this disease.
Alopecia areata
We investigate the autoimmune basis and new options that stimulate hair growth.
Hidradenitis suppurativa
We analyze genetic and immune factors to improve the approach to this disease.
Atopic dermatitis
We explore the alteration of the skin barrier and the mediators that cause inflammation.
Nodular prurigo
We study the origin of severe itching and seek therapies to alleviate the discomfort.
Vitiligo
We investigate the autoimmune process that affects melanocytes and how to recover pigmentation.
Notalgia paresthetica
We study the neuropathic origin of itching and therapies to control the symptoms.